Public Employees Retirement System Of Ohio Arvinas, Inc. Transaction History

Public Employees Retirement System Of Ohio

  • $22.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 19, 2023
SELL
$19.64 - $28.21 $61,924 - $88,946
-3,153 Reduced 49.01%
3,280 $64,000
Q3 2023

Nov 15, 2023
SELL
$19.64 - $28.21 $61,924 - $88,946
-3,153 Reduced 49.01%
3,280 $64,000
Q4 2022

Dec 19, 2023
BUY
$32.47 - $57.24 $102,377 - $180,477
3,153 Added 96.13%
6,433 $220,000
Q4 2022

Feb 15, 2023
SELL
$32.47 - $57.24 $37,989 - $66,970
-1,170 Reduced 15.39%
6,433 $220,000
Q1 2021

May 14, 2021
BUY
$58.19 - $91.37 $442,418 - $694,686
7,603 New
7,603 $503,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email